RecallRadar

FDA Device recall Z-2195-2019

Lantis 6.1 Commander, Model # 5493072 - Product Usage: Lantis Treatstation is to allow the radiation therapist to deliver treatment to the…

On 2019-08-14 the FDA classified a Class II recall of Lantis 6.1 Commander, Model # 5493072 - Product Usage: Lantis Treatstation is to allow the radiation therapist to deliver treatment to the… by Siemens Medical Solutions Usa, citing potentially affected by the Microsoft Windows Remote Desktop Protocol (RDP) vulnerability.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2195-2019
ClassificationClass II
Statusterminated
Initiated2019-07-10
Published2019-08-14
Last updated2026-09-13 11:55 UTC
CompanySiemens Medical Solutions Usa
DistributionAL, FL, GA, IL, NC, NJ, NY, OH, OK, PA, WV, WY

Product

Lantis 6.1 Commander, Model # 5493072 - Product Usage: Lantis Treatstation is to allow the radiation therapist to deliver treatment to the patient using the mevatron and all available accessories. This entails selecting a patient, selecting today s treatment for that patient, setting up and delivering the treatment fields and recording the delivered treatment. Treatstation supports auto sequencing, a process of automatically downloading a group of fields or segments from the verification and record system to the control of the linear accelerator sequentially, without user intervention. In addition, Lantis Treatstation supports intensity modulation, a process of shaping, modifying and moving the beam around a target to maximize the dose at the target and minimize the dose to normal structures.

Reason

Potentially affected by the Microsoft Windows Remote Desktop Protocol (RDP) vulnerability

Identifiers

code_infoSerial Number 93-1158 93-0803

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2195-2019%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.